Diversified Healthcare Trust (NASDAQ:DHC) has a beta value of 0.94 and has seen 706,599 shares traded in the last trading session. The company, currently valued at $826.88 Million, closed the last trade at $3.47 per share which meant it lost -$0.23 on the day or -6.08% during that session. The DHC stock price is -194.24% off its 52-week high price of $10.21 and 42.36% above the 52-week low of $2. If we look at the company’s 10-day average daily trading volume, we find that it stood at 997.26 Million shares traded. The 3-month trading volume is 1.35 Million shares.

The consensus among analysts is that Diversified Healthcare Trust (DHC) is a Hold stock at the moment, with a recommendation rating of 3.1. 1 analysts rate the stock as a Sell, while none rate it as Overweight. 5 out of 8 have rated it as a Hold, with 1 advising it as a Buy. 1 have rated the stock as Underweight. The expected earnings per share for the stock is -$0.15.

Diversified Healthcare Trust (NASDAQ:DHC) trade information

Despite being -6.08% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Oct 15 when the DHC stock price touched $3.73-6 or saw a rise of 6.84%. Year-to-date, Diversified Healthcare Trust shares have moved -58.83%, while the 5-day performance has seen it change -2.39%. Over the past 30 days, the shares of Diversified Healthcare Trust (NASDAQ:DHC) have changed -9.27%. Short interest in the company has seen 11.64 Million shares shorted with days to cover at 8.62.

Wall Street analysts have a consensus price target for the stock at $3.95, which means that the shares’ value could jump 13.83% from current levels. The projected low price target is $2.75 while the price target rests at a high of $7. In that case, then, we find that the current price level is +101.73% off the targeted high while a plunge would see the stock lose -20.75% from current levels.

Diversified Healthcare Trust (DHC) estimates and forecasts

Figures show that Diversified Healthcare Trust shares have underperformed across the wider relevant industry. The company’s shares have gained +39.56% over the past 6 months, with this year growth rate of -38.93%, compared to -3.2% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are -25% and 36.4% for the next quarter. Revenue growth from the last financial year stood is estimated to be +58.6%.

7 analysts offering their estimates for the company have set an average revenue estimate of $399.31 Million for the current quarter. 7 have an estimated revenue figure of $397.32 Million for the next quarter concluding in December 01, 2020. Year-ago sales stood $255.83 Million and $256.04 Million respectively for this quarter and the next, and analysts expect sales will grow by 56.1% for the current quarter and 55.2% for the next.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -19.7% over the past 5 years. Earnings growth for 2020 is a modest -130.7% while over the next 5 years, the company’s earnings are expected to increase by 3.2%.

DHC Dividends

Diversified Healthcare Trust is expected to release its next earnings report between November 05 and November 05 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 0.04 at a share yield of 1.08%. The company’s dividend yield has gone up over the past 12 months, with a 5 Year Average Dividend Yield of 9.88%.

Diversified Healthcare Trust (NASDAQ:DHC)’s Major holders

Insiders own 1.29% of the company shares, while shares held by institutions stand at 71.38% with a share float percentage of 72.31%. Investors are also buoyed by the number of investors in a company, with Diversified Healthcare Trust having a total of 334 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 38.62 Million shares worth more than $170.89 Million. As of June 29, 2020, Vanguard Group, Inc. (The) held 16.23% of shares outstanding.

The other major institutional holder is Blackrock Inc., with the holding of over 38.12 Million shares as of June 29, 2020. The firm’s total holdings are worth over $168.67 Million and represent 16.02% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are iShares Core S&P Smallcap ETF and Vanguard Specialized-Real Estate Index Fund. As of August 30, 2020, the former fund manager holds about 6.27% shares in the company for having 14918861 shares of worth $56.69 Million while later fund manager owns 10.61 Million shares of worth $41.32 Million as of July 30, 2020, which makes it owner of about 4.46% of company’s outstanding stock.